News
Ditch Labs Appoints Moishe Liberman, MD, PhD, FACS, FRCSC, as Chief Medical Officer
Ditch Labs, Inc. is honored to appoint Dr. Moishe Liberman as Chief Medical Officer (CMO). Dr. Liberman is a minimally invasive thoracic surgeon trained at Harvard University who has run over 40 clinical trials at the CHUM Research Center over the last 13 years in Thoracic Surgical Oncology.
Ditch Completes Successful Integration And Testing Of Its Second-Generation Alpha Product, Ready For Nonclinical Testing
Ditch Labs, Inc. completing the successful integration and testing of its second-generation alpha product marks a green status for the upcoming nonclinical testing.